Dr. Brittain F Kulow, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1112 Hospital Rd Ste A, Fort Walton Beach, FL 32547 Phone: 850-314-7546 Fax: 850-314-7542 |
George Edwin Vonhilsheimer Iv, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 922 Mar Walt Dr, Suite 100, Fort Walton Beach, FL 32547 Phone: 850-796-3376 Fax: 850-522-8354 |
Zachary Ashton Carter, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 912 Mar Walt Dr, Fort Walton Beach, FL 32547 Phone: 850-314-7546 Fax: 850-654-3320 |
Dr. Cather Marie Cala Mckay, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 912 Mar Walt Dr, Fort Walton Beach, FL 32547 Phone: 850-314-7546 Fax: 850-654-3320 |
Dr. Norman R Friedman, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1110 Hospital Road, Dermatology Department, Fort Walton Beach, FL 32547 Phone: 850-863-8281 Fax: 850-863-8206 |
News Archive
A new study of the medical records for nearly half a million women in Denmark reveals significantly higher maternal death rates following abortion compared to delivery. This finding has confirmed similar population studies conducted in Finland and the United States, but contradicts the widely held belief that abortion is safer than childbirth.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line data from its open-label phase IIIb trial evaluating XIAFLEX for the treatment of adult Dupuytren's contracture patients with multiple palpable cords. The Company enrolled 60 patients at eight sites throughout the U.S. and Australia.
Developing brains in newborns have a sizable pool of a certain type of immature progenitor cell that can be expanded and induced to replace cells lost to brain injury.
A study of the options for reducing cancer incidence and mortality among women who have been treated for precancerous cervical lesions found that an annual conventional Pap smear is a cost effective strategy.
SynCardia Systems, Inc. announced today that Brigham and Women's Hospital in Boston, and University of Iowa (UI) Hospitals and Clinics in Iowa City, Iowa, have begun certification to implant the SynCardia temporary Total Artificial Heart. Brigham and Women's will complete Phase I of certification on Nov. 1 & 2, and UI Hospitals and Clinics completed Phase I on Oct. 21 & 22.
› Verified 5 days ago